SARS-CoV-2 Testing of Emergency Department Patients Using cobas Liat and eazyplex Rapid Molecular Assays.

Publication date: Jul 01, 2023

Type	Source	Name
disease	MESH	Emergency
disease	IDO	assay
disease	MESH	infection
disease	VO	Severe acute respiratory syndrome coronavirus 2
disease	MESH	SARS CoV 2 infection
disease	MESH	critically ill
disease	VO	time
drug	DRUGBANK	Gold
disease	VO	population
drug	DRUGBANK	Coenzyme M
disease	MESH	clinical relevance
disease	VO	viable
drug	DRUGBANK	Trestolone
disease	VO	report
disease	IDO	site
drug	DRUGBANK	Phosphate ion
disease	VO	device
disease	VO	protocol
disease	MESH	sore throat
disease	MESH	anorexia
drug	DRUGBANK	Phenylpropanolamine
disease	MESH	viral shedding
disease	IDO	infectivity
disease	VO	gene
disease	MESH	influenza
drug	DRUGBANK	Ademetionine
drug	DRUGBANK	Etoperidone
disease	MESH	shock
drug	DRUGBANK	(S)-Des-Me-Ampa
disease	IDO	facility
disease	VO	organization

(Visited 1 times, 1 visits today)

The next generation in scientific exploration and research